CClinicalTrials.gg
CompletedNCT04400162Updated Apr 28, 2021

Augmentation of Depression Treatment by Gamified Network Retraining

An interventional study of Usability of the CCT and Changes in regards to the depressive disorder in Depression Mild, Cognitive Impairment and Cognitive Dysfunction, sponsored by University Hospital Tuebingen. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-28.

Sponsored by University Hospital Tuebingen · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Major depressive disorder (MDD) is a highly prevalent and debilitating mental disorder with a high lifetime prevalence of 16-20%. Particularly for people with low socio-economic status, the existing and effective treatment options are hard to reach and show weaker effectivities. There is a potential to ameliorate depressive symptoms and improve quality of life in persons with mild-to-moderate depression by providing access to stimulating computerized trainings. Single computerized trainings that target depressive symptoms have been tested in laboratory and clinical settings so far. To date, innovative market access and confirmatory studies are missing for a large-scale implementation of such trainings. Thereby, the present work will foster a digitalized training paradigm (Paced-Auditory Serial Addition Task; PASAT) which was previously shown to reduce depressive symptoms, but in a novel innovative and gamified form on a tablet-PC handed out to participants. Different versions of the same training paradigm that comprise additional game elements will be compared. The feasibility study will gather data on effect size estimates of symptom severity reduction, user experience and usage in an ecological valid setting.

02

Conditions studied

  • Depression Mild
  • Cognitive Impairment
  • Cognitive Dysfunction
  • Depressive Disorder
  • Depression
03

In context

Depression

8,055 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's enrollment of 32 is below the median of 84 across 6,718 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University Hospital Tuebingen is the lead sponsor of 476 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Full age (> 18 years old)
  • Consent
  • German mother tongue
  • Presence of mild-to-moderate depressive symptoms (MADRS > 10 and \< 34 and confirmation of depressive symptoms in M.I.N.I. diagnostic interview)
  • Stable or no medication with antidepressant drugs or other psychoactive agents (at least for 6 weeks)
  • No or current psychotherapy

Exclusion criteria

Exclusion Criteria:

  • Presence of schizophrenia / psychotic disorder (according to M.I.N.I. diagnostic interview)
  • Cognitive impairment
  • Epilepsy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    CCT (standard)

    This arm consists of the CCT in a standard variant that provides the basic training experience without any added gaming elements.

    Behavioral: Usability of the CCT · Behavioral: Changes in regards to the depressive disorder

  • Experimental
    CCT (game)

    This arm consists of the same CCT as the standard version, however pre-defined gaming elements that are thought to increase usability as well as interest in the intervention have been added.

    Behavioral: Usability of the CCT · Behavioral: Changes in regards to the depressive disorder

Interventions

  • BehavioralUsability of the CCT

    Evaluation of the usability of the provided training.

  • BehavioralChanges in regards to the depressive disorder

    Evaluation of depressive symptoms and whether they change in regards to the provided training.

06

What researchers measure

Primary outcomes

  1. Usability and feasibility on the UsExQ [User Experience Questionnaire]

    Usage frequency, performed calculations during each session and over the course of the participation. Feedback on perceived quality of the device and software. Acceptance of training and willingness to continue (open text questionnaires; usability ranging from -- to ++ on a 5 point scale with negative responses corresponding to a more negative user experience).

    Time frame: 2-4 weeks

  2. MADRS [Montgomery-Asberg Depression Rating Scale]

    Evaluation of depressive symptoms over the course of the intervention on the MADRS (lower numberes show decrease in depressive symptoms; range from 0-60).

    Time frame: 18-20 weeks

Secondary outcomes

  1. WHO-5 [WHO-Five Well-Being Index] (overall wellbeing)

    Changes of the score over the course of the experiment (lower numbers showing decrease of perceived wellbeing; range from 0-25).

    Time frame: 18-20 weeks

  2. IDS-SR [Inventory of Depressive Symptomatology - Self Report] (depression)

    Changes of the score over the course of the experiment (lower numbers showing decrease of symptoms; range from 0-84).

    Time frame: 18-20 weeks

  3. RSES [Rosenberg Self Esteem Scale] (self esteem)

    Changes of the score over the course of the experiment (higher scores showing increase of self-esteem; range from 0-30).

    Time frame: 18-20 weeks

  4. SRQ [State Rumination Questionnaire] (rumination)

    Changes of the score over the course of the experiment (lower scores showing decrease of ruminating thoughts; range from 10-50).

    Time frame: 18-20 weeks

07

Study locations

1 site
  • Department of Psychiatry and Psychotherapy, University of Tübingen
    Tübingen, 72076, Germany
08

References and documents

Publications

  • Weller S, Schroeder PA, Plewnia C. Gamification improves antidepressant effects of cognitive control training-A pilot trial. Front Digit Health. 2022 Oct 21;4:994484. doi: 10.3389/fdgth.2022.994484. eCollection 2022. PubMed 36339520 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04400162
Lead sponsor
University Hospital Tuebingen
Responsible party
Christian Plewnia, MD (Doctor of Psychiatry and Psychotherapy, University Hospital Tuebingen) — Principal investigator
First posted
May 22, 2020
Start date
May 14, 2020
Primary completion
Dec 31, 2020
Completion
Mar 15, 2021
Last update
Apr 28, 2021

Study contacts

Christian Plewnia, MD
principal investigator · University Hospital Tübingen

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion